Breathing Labs
Home
How To Start
Products
Breathing+ Package
Toys Package
Q&A
Login

Covid19

7Dec

Remdesivir injection redistributed as per requirement in Chhattisgarh

Posted by: admin Categories: Covid19
Comments Off on Remdesivir injection redistributed as per requirement in Chhattisgarh

Raipur, 06 May 2021 1200 Remdesivir Injection redistributed as required by the Health Department to eight districts for control and rescue of Kovid-19. In this regard, the Director Health Services has instructed all the Chief Medical and Health Officers to establish immediate coordination and ensure that they receive the injection and distribute it. Similarly, a […]

Read more
4Dec

FDA clears use of Lilly’s Covid-19 antibody therapy for kids

Posted by: admin Categories: Covid19
Comments Off on FDA clears use of Lilly’s Covid-19 antibody therapy for kids

The US Food and Drug Administration on Friday authorized the use of Eli Lilly’s COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness. The therapy, bamlanivimab plus etesevimab, was previously authorized for children aged 12 years and older and weighed at least 88 […]

Read more
4Dec

Remdesivir in Pregnant Patients with Novel Coronavirus Disease 2019: Case Series

Posted by: admin Categories: Covid19
Comments Off on Remdesivir in Pregnant Patients with Novel Coronavirus Disease 2019: Case Series

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Renu Singh, Professor, Department of Obstetrics and Gynecology, King George’s Medical University, Lucknow, India, 226003. Anjoo Agarwal, Professor, Department of Obstetrics and Gynecology, King George’s Medical University, Lucknow, India, 226003. Mona Asnani, Associate Professor, Department of Obstetrics and […]

Read more
2Dec

Mexico approves emergency use of Lilly’s COVID-19 treatment

Posted by: admin Categories: Covid19
Comments Off on Mexico approves emergency use of Lilly’s COVID-19 treatment

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar MEXICO CITY, Dec 1 (Reuters) – Mexico’s health regulator Cofepris said on Wednesday it had approved U.S. pharmaceutical firm Eli Lilly and Co’s (LLY.N) antibody treatment against COVID-19 for emergency use with […]

Read more
1Dec

Antibiotics | Free Full-Text | Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic

Posted by: admin Categories: Covid19
Comments Off on Antibiotics | Free Full-Text | Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic

MDPI and ACS Style Poliseno, M.; Gallo, C.; Cibelli, D.C.; Minafra, G.A.; Bottalico, I.F.; Bruno, S.R.; D’Errico, M.L.; Montemurro, L.; Rizzo, M.; Barbera, L.; Custodero, G.E.; La Marca, A.; Lo Muzio, D.; Miucci, A.; Santantonio, T.A.; Lo Caputo, S. Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic. Antibiotics 2021, 10, 1477. […]

Read more
30Nov

Emmes completes third ACTT clinical trial for COVID

Posted by: admin Categories: Covid19
Comments Off on Emmes completes third ACTT clinical trial for COVID

Read Article Emmes yesterday announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus Remdesivir compared to Remdesivir alone in hospitalised adults with COVID-19, according to a […]

Read more
30Nov

NRx Prescription drugs Shares Rise 18% After Zyesami Evaluation

Posted by: admin Categories: Covid19
Comments Off on NRx Prescription drugs Shares Rise 18% After Zyesami Evaluation

By Chris Wack NRx Prescription drugs Inc. shares have been up 18%, to $7.96, after the corporate stated it has accomplished an evaluation to establish medical proof that signifies a considerable enchancment after therapy with Zyesami aviptadil in sufferers with important Covid-19 and respiratory failure over present therapies reminiscent of remdesivir. Quantity for the inventory […]

Read more
29Nov

NRx Pharma Shares Rise 39% After Completing Zyesami Analysis

Posted by: admin Categories: Covid19
Comments Off on NRx Pharma Shares Rise 39% After Completing Zyesami Analysis

By Chris Wack NRx Pharmaceuticals Inc. shares were up 39%, to $9.47, in premarket trading after the company said it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with Zyesami aviptadil in patients with critical Covid-19 and respiratory failure over existing therapies such as remdesivir. The analysis showed […]

Read more
28Nov

Indonesia Secures Drug Supply with Remdesivir, Favipiravir Patents

Posted by: admin Categories: Covid19
Comments Off on Indonesia Secures Drug Supply with Remdesivir, Favipiravir Patents

Summary Indonesia President Joko “Jokowi” Widodo issued regulations to fulfill the availability of  COVID-19 drugs, Remdesivir and Favipiravir, as stipulated in the Presidential Regulation (Perpres) No. 100/2021 and 101/2021 on patents for Remdesivir and Favipirapir. “The government needs to establish a policy on access to drugs that are currently still protected by patents,” reads the […]

Read more
27Nov

Structural Bioinformatics Used to Predict the Protein Targets of Remdesivir and Flavones in SARS-CoV-2 Infection

Posted by: admin Categories: Covid19
Comments Off on Structural Bioinformatics Used to Predict the Protein Targets of Remdesivir and Flavones in SARS-CoV-2 Infection

Title:Structural Bioinformatics Used to Predict the Protein Targets of Remdesivir and Flavones in SARS-CoV-2 Infection VOLUME: 17 Author(s):Avram Speranta, Laura Manoliu, Catalina Sogor, Maria Mernea*, Corina Duda Seiman, Daniel Duda Seiman and Carmen Chifiriuc Affiliation:University of Bucharest, Faculty of Biology, Department of Anatomy, Animal Physiology and Biophysics, 36-46 Bd. M. Kogalniceanu, 050107, Bucharest, University of […]

Read more
26Nov

Ritonavir and Veklury Interactions Checker

Posted by: admin Categories: Covid19
Comments Off on Ritonavir and Veklury Interactions Checker

This report displays the potential drug interactions for the following 2 drugs: ritonavir Veklury (remdesivir) Edit list (add/remove drugs) Interactions between your drugs Remdesivir may cause liver problems, and using it with other medications that can also affect the liver such as ritonavir may increase that risk. Blood tests to monitor liver function should be […]

Read more
26Nov

Computational hunting of natural active compounds as an alternative for Remdesivir to target RNA-dependent polymerase

Posted by: admin Categories: Covid19
Comments Off on Computational hunting of natural active compounds as an alternative for Remdesivir to target RNA-dependent polymerase

The hunt for potential lead/drug molecules from different resources, especially from natural resources, for possible treatment of COVID-19 is ongoing. Several compounds have already been identified, but only a few are good enough to show potential against the virus. Among the identified druggable target proteins of SARS-CoV-2, this study focuses on non-structural RNA-dependent RNA polymerase […]

Read more
24Nov

#Faktenfuchs: Ivermectin derzeit kein Medikament gegen Corona

Posted by: admin Categories: Covid19
Comments Off on #Faktenfuchs: Ivermectin derzeit kein Medikament gegen Corona

Bayerische Meta-Studie fand bisher keine Wirksamkeit von Ivermectin Um zu einer klaren Aussage zu kommen, sind in der Medizin und in anderen Wissenschaften Meta-Studien gängige Praxis. Dabei werden die bereits vorhandenen Studien mit hohen Qualitätsstandards gebündelt untersucht. Das kumulierte Ergebnis gilt dann meist als besonders aussagekräftig. Auch für Ivermectin gibt es solche Meta-Studien bereits, eine […]

Read more
24Nov

Stable Isotope Products | CLEARSYNTH

Posted by: admin Categories: Covid19
Comments Off on Stable Isotope Products | CLEARSYNTH

Clearsynth is a technology based, research driven enterprise with the World’s Largest Inventory of Reference Standards & Research Chemicals. We aim to enable the research community in accelerated discovery via synthesis of complex and difficult to make compounds.We specialize in Innovative Organic chemistry and synthesis of Unique Complex Molecules, Stable Isotope Labelled compounds, Metabolites, Impurities, […]

Read more
21Nov

Head of State announces that a shipment of medicines for patients with COVID-19 will arrive in Venezuela

Posted by: admin Categories: Covid19
Comments Off on Head of State announces that a shipment of medicines for patients with COVID-19 will arrive in Venezuela

This Saturday, the President of the Republic, Nicolás Maduro, during the reception of the international observers who will participate in the Megalections on November 21, reported that a flight with a medicine to combat COVID-19 will arrive in Venezuela. “Tomorrow, confirmed, the flight arrives with enough doses of that pill to continue saving and reinforcing […]

Read more
20Nov

Remdesivir against COVID-19 and Other Viral Diseases. | Clin Microbiol Rev;34(1)2020 12 16.

Posted by: admin Categories: Covid19
Comments Off on Remdesivir against COVID-19 and Other Viral Diseases. | Clin Microbiol Rev;34(1)2020 12 16.

ABSTRACT Patients and physicians worldwide are facing tremendous health care hazards that are caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) pandemic. Remdesivir (GS-5734) is the first approved treatment for severe coronavirus disease 2019 (COVID-19). It is a novel nucleoside analog with a broad antiviral activity spectrum among RNA viruses, including […]

Read more
20Nov

Vaccine boosters another tool to protect from Covid-19 virus

Posted by: admin Categories: Covid19
Comments Off on Vaccine boosters another tool to protect from Covid-19 virus

The expansion of booster shots is just the latest addition to the arsenal of ways to protect people from the Covid-19 virus. WAAY 31 spoke with a state health official about the ongoing fight in this pandemic. Dr. Karen Landers with the Alabama Department of Public Health said the coronavirus isn’t going to magically disappear, […]

Read more
19Nov

St. Cloud Hospital is Using These Treatments for COVID-19

Posted by: admin Categories: Covid19
Comments Off on St. Cloud Hospital is Using These Treatments for COVID-19

Treatments of the COVID-19 virus have changed since St. Cloud Hospital and CentraCare was first faced with the challenge of working with COVID-19 patients in the spring of 2020.  CentraCare Spokesman Dr. George Morris joined me on WJON today.  These are the treatments they use for COVID-19 patients: Remdesivir – Is an antiviral.  Dr. Morris […]

Read more
« Older posts
Newer posts »